- Home
- ULBI vs KOD Comparison
ULBI vs KOD Comparison
Compare ULBI & KOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ULBI
- KOD
- Stock Information
- Founded
- ULBI 1990
- KOD 2009
- Country
- ULBI United States
- KOD United States
- Employees
- ULBI N/A
- KOD N/A
- Industry
- ULBI Industrial Machinery/Components
- KOD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ULBI Miscellaneous
- KOD Health Care
- Exchange
- ULBI Nasdaq
- KOD Nasdaq
- Market Cap
- ULBI 158.1M
- KOD 186.3M
- IPO Year
- ULBI 1992
- KOD 2018
- Fundamental
- Price
- ULBI $7.67
- KOD $5.35
- Analyst Decision
- ULBI Strong Buy
- KOD Hold
- Analyst Count
- ULBI 1
- KOD 5
- Target Price
- ULBI $14.00
- KOD $3.25
- AVG Volume (30 Days)
- ULBI 63.5K
- KOD 373.2K
- Earning Date
- ULBI 11-08-2024
- KOD 11-19-2024
- Dividend Yield
- ULBI N/A
- KOD N/A
- EPS Growth
- ULBI 115.20
- KOD N/A
- EPS
- ULBI 0.54
- KOD N/A
- Revenue
- ULBI $165,152,000.00
- KOD N/A
- Revenue This Year
- ULBI $10.59
- KOD N/A
- Revenue Next Year
- ULBI $8.72
- KOD N/A
- P/E Ratio
- ULBI $14.73
- KOD N/A
- Revenue Growth
- ULBI 9.95
- KOD N/A
- 52 Week Low
- ULBI $6.36
- KOD $1.86
- 52 Week High
- ULBI $13.39
- KOD $7.77
- Technical
- Relative Strength Index (RSI)
- ULBI 34.02
- KOD 76.60
- Support Level
- ULBI $7.50
- KOD $3.73
- Resistance Level
- ULBI $8.17
- KOD $5.58
- Average True Range (ATR)
- ULBI 0.36
- KOD 0.28
- MACD
- ULBI -0.10
- KOD 0.11
- Stochastic Oscillator
- ULBI 9.00
- KOD 88.02
About ULBI Ultralife Corporation
Ultralife Corp provides products and services ranging from power solutions to communications and electronics systems to customers across the globe in the government and defense, medical, safety and security, energy, and industrial sectors. The company designs, manufactures, installs, and maintains power and communications systems including rechargeable and non-rechargeable batteries, charging systems, communications and electronics systems and accessories, and custom-engineered systems. The company's segments include Battery and Energy Products, and Communications Systems. It generates maximum revenue from the Battery and Energy Products segment, and from the U.S. The Battery & Energy Products segment includes Lithium 9-volt, cylindrical, and various other non-rechargeable batteries.
About KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is KSI-301, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD.